Fluorescent Antibody-Drug Conjugate Data for Pancreatic Cancer Theranostics

This dataset supports a study presenting a method for synthesizing a dual-labeled fluorescent antibody-drug conjugate (ADC) for targeted therapy and molecular imaging of pancreatic cancer. The research demonstrates the ADC's binding, internalization, cytotoxicity in vitro, and its efficacy in tumor detection and growth inhibition in a mouse xenograft model. The dataset includes experimental results from immunofluorescent staining, flow cytometry, and in vivo imaging.

Use Cases

• Analyze immunofluorescent staining data to quantify the selective binding of the fluorescent ADC to CEA-positive BxPC-3 pancreatic cancer cells.
• Use flow cytometry data to evaluate the internalization kinetics of the PEGylated fluorophore-conjugated antibody in target cell lines.
• Compare in vivo imaging data from athymic mouse xenografts to assess the fluorescent ADC's efficacy for tumor detection versus unconjugated drug controls.
• Correlate cytotoxicity assay results with ADC concentration to model the therapeutic dose-response relationship for the paclitaxel-conjugated antibody.

Strengths

• Data is derived from a published study demonstrating a novel theranostic biopharmaceutical for pancreatic cancer.
• Experimental validation includes both in vitro (cell binding, internalization, cytotoxicity) and in vivo (mouse xenograft) model systems.
• The associated research article provides detailed methodological context for the data generation.

Limitations

• The dataset scope is specific to a single CEA-targeting antibody and a BxPC-3 pancreatic cancer cell line, limiting generalizability.
• Sample sizes for in vivo mouse studies are not specified, which may affect statistical power.
• Data generation relies on non-site-specific, amine-reactive conjugation chemistry, which may result in heterogeneous conjugate populations.

Provenance

Source

Dryad digital repository.

Collection Method

Experimental data generated from laboratory studies of a synthesized fluorescent antibody-drug conjugate.

Freshness

Data was last updated in June 2020.